Do differences exist between chronic hepatitis C genotypes 2 and 3?

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Six hepatitis C virus (HCV) genotypes are known, with genotype 1 being the most common globally.
• Genotypes 2 and 3 are often studied together, limiting understanding of their individual characteristics.
• This study aimed to differentiate clinical, epidemiological, laboratory, and histological aspects between HCV-2 and HCV-3.

Purpose of the Study:

• To investigate and compare clinical, epidemiological, laboratory, and histological parameters between patients infected with hepatitis C virus genotype 2 (HCV-2) and genotype 3 (HCV-3).
• To establish distinct profiles for HCV-2 and HCV-3 to inform targeted research and treatment strategies.

Main Methods:

• Retrospective analysis of 306 patients with chronic hepatitis C, divided into HCV-2 (n=50) and HCV-3 (n=256) groups.
• Quantitative HCV-RNA analysis using TaqMan® real-time PCR.
• HCV genotyping determined by sequencing the 5'-untranslated region.

Main Results:

• HCV-3 patients were younger (p=0.002) and had less arterial hypertension (p=0.03) compared to HCV-2.
• HCV-3 group showed higher serum albumin (p=0.01), more advanced liver fibrosis (p=0.03), and increased steatosis (p=0.001).
• Subtypes 2b and 3a were most prevalent in HCV-2 and HCV-3 groups, respectively.

Conclusions:

• Significant clinical and histological differences exist between HCV-2 and HCV-3 infections.
• These disparities underscore the necessity of analyzing HCV genotypes 2 and 3 independently.
• Separate analysis can lead to more precise understanding and management of chronic hepatitis C.